Advertisement
In an unexpected move, the IOM called for an end to the 510(k) clearance process that has been under revision for the past year and proposed that Congress enact legislation for a new regulatory system after the FDA determines how to create one. The 510(k) process is the current pathway that authorizes low-risk medical devices, including those for imaging.

SOURCE

Advertisement
Advertisement